Ji-hang Yuan

No. 800 Xiang Yin Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

SLC38A4 promotes Kupffer cell phagocytosis and suppresses tumor liver metastasis.

SLC38A4 promotes Kupffer cell phagocytosis and suppresses tumor liver metastasis.

Journal: Experimental & molecular medicine

Published: September 09, 2025

m6A-modified MIR670HG suppresses tumor liver metastasis through enhancing Kupffer cell phagocytosis.

m6A-modified MIR670HG suppresses tumor liver metastasis through enhancing Kupffer cell phagocytosis.

Journal: Cellular and molecular life sciences : CMLS

Published: January 24, 2025

METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression.

METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression.

Journal: Signal transduction and targeted therapy

Published: October 07, 2023

Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription.

Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription.

Journal: Journal of translational medicine

Published: May 16, 2023

The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity.

The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity.

Journal: Nature immunology

Published: January 18, 2023

Identification of novel factors that affect the onset of idiopathic chronic pancreatitis: The role for microRNA-323b-5p.

Identification of novel factors that affect the onset of idiopathic chronic pancreatitis: The role for microRNA-323b-5p.

Journal: The journal of gene medicine

Published: July 28, 2022

METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.

METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.

Journal: Cellular & molecular biology letters

Published: April 06, 2022

SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.

SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.

Journal: British journal of cancer

Published: April 14, 2021

CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression.

CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 28, 2017

Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.

Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.

Journal: Molecular cancer

Published: February 28, 2017

The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.

The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.

Journal: Nature cell biology

Published: January 03, 2017

An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.

An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 01, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026